Skip to Content
chevron-left chevron-right chevron-up chevron-right chevron-left arrow-back star phone quote checkbox-checked search wrench info shield play connection mobile coin-dollar spoon-knife ticket pushpin location gift fire feed bubbles home heart calendar price-tag credit-card clock envelop facebook instagram twitter youtube pinterest yelp google reddit linkedin envelope bbb pinterest homeadvisor angies

Our Mission

Urology Associates has built one of the region’s most active urology-specific clinical research programs, giving our patients access to emerging treatments years before they may be widely available. Our Clinical Research Department manages dozens of active studies at any given time, spanning cancer care, benign urologic conditions, and men’s health — all conducted under strict regulatory oversight and in partnership with leading research sponsors.

Where We Focus Our Research

  • Bladder & Prostate Cancer: Our longest-standing area of research strength, including next-generation therapies for high-risk and recurrent disease.
  • BPH & Lower Urinary Tract Symptoms (LUTS): Studies evaluating new options for enlarged prostate and related urinary symptoms.
  • Kidney Stones, Including Surgical Stone Disease: Research into prevention, treatment, and surgical approaches for stone disease.
  • Men’s Health: Studies addressing a range of men’s urologic and reproductive health conditions.
  • Genetics & Biomarker Research: Investigating the genetic and molecular factors behind urologic disease to guide more personalized care.

Our Research Program at a Glance

What Is a Clinical Trial — and Is It Right for You?

A clinical trial is a carefully designed research study that evaluates a new treatment, device, or approach to care. Every study conducted at Urology Associates is reviewed and approved by an Institutional Review Board (IRB) before it begins, and is conducted according to Good Clinical Practice (GCP) standards — the same ethical and safety framework used at research institutions nationwide. Participation is always voluntary: you may choose to join a study and to stop at any time.

Interested in learning more? Patients must schedule an appointment with a Urology Associates provider to discuss their condition and treatment options. Please note that not every study is right for every patient — eligibility depends on diagnosis, health history, and the requirements of each study protocol.

Common Questions about Clinical Research

 

  • Is there a cost to participate? Many study-related visits, procedures, and study medications are provided at no cost to participants; your care team will review any potential costs specific to a study before you enroll.
  • Will my insurance be billed? Study-related items are typically covered by the study sponsor, not billed to insurance; routine care unrelated to the study may still be billed normally.
  • Can I stop participating once I’ve enrolled? Yes. Participation is voluntary, and you may withdraw from a study at any time without affecting your regular medical care.
  • Is my information kept private? Yes. All studies follow strict patient privacy protections under HIPAA, and your identifiable information is safeguarded throughout the study.
  • How do I know if a study is safe? Every study is reviewed and approved by an independent Institutional Review Board (IRB) before it begins, and is monitored throughout to protect participant safety.

Why Choose Urology Associates

Partner with Our Research Program

Urology Associates offers sponsors and CROs access to an experienced clinical research team, established regulatory and compliance infrastructure, and a specialty urology patient population. Our research staff complete Good Clinical Practice (GCP) and CITI Program training, and all studies undergo Institutional Review Board (IRB) review and approval prior to patient enrollment.

Our facility is equipped to support investigational product management, including two -20°C freezers and 24-hour remote IP monitoring for temperature and humidity. We follow structured study start-up processes and established protocols designed to maintain study integrity, regulatory compliance, and the protection of patient information in accordance with HIPAA and PHI-handling requirements.

Click here to view IBC (WCG) Meeting Minutes.